Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
ethyl 2-cyano-3-oxobutanoate
EC Number:
700-172-3
Cas Number:
634-55-9
Molecular formula:
C7 H9 NO3
IUPAC Name:
ethyl 2-cyano-3-oxobutanoate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
olive oil
Doses:
The animals of the treated group received an effective dose of 2000 or 300 mg/kg body of the test item ETHYL-2-CYANO-3-OXOBUTANOATE :
In a first step of the study, the preparation was administered by gavge, assupplied, under a volume of 1.84 mL/kg body weight (corresponding to 2 g/kg, according to the calculated density) using a suitable syringe graduated fitted with an oesophageal metal canula.

In a second and third step of the study, 0.28 mL of the test item (corresponding to 0.3 g, according to the calculated density) was added to 1.56 mL of olive oil and manually stirred to obtain a yellow solution. The preoparation was administered by gavage under a volume of 1.84 mL/ kg body weight using a suitable syringe graduated fitted with an oesophageal metal canula.
No. of animals per sex per dose:
Groupe treated (2000 mg/kg) : 3 female rats Rf4285 to Rf4287 (step 1)
Gropu treated (300 mg/kg) : 3 female rats Rf 4288 to 4290 (Step 2) + 3 female rats Rf 4294 to 4296 (Step 3)
Control animals:
yes

Results and discussion

Effect levelsopen allclose all
Sex:
female
Dose descriptor:
LD50
Effect level:
> 300 - < 2 000 mg/kg bw
Based on:
test mat.
Sex:
female
Dose descriptor:
LD50
Effect level:
500 mg/kg bw
Mortality:
It was noted the death of 3 rats treated at 2000 mg/kg b.w. (3/3) between 3 hours 50 minutes and
4 hours post-dose. The mortalities were preceded by an absence or a decrease in spontaneous activity
(3/3), in Preyer’s reflex (2/3), in muscle tone (2/3) and in righting reflex (1/3), a dyspnea or a
bradypnea (2/3), a partial ptosis (2/3) and a mydriasis or a myosis (2/3).
The macroscopical examination of the dead animals revealed a white coloration of the forestomach, a
greenish coloration of the corpus associated with red spots (3/3), and a bright red coloration of the
lungs (1/3).
No mortality occurred in the animals treated at 300 mg/kg b.w.
No clinical signs related to the administration of the test item were observed.
A decrease in the body weight gain was noted on day 2: +4% compared to day 0 versus +15% in the
historical control group. The animals recovered a normal body weight on day 7.
The macroscopical examination of the animals at the end of the study did not reveal treatment-related
changes.

Applicant's summary and conclusion

Interpretation of results:
harmful
Remarks:
Migrated information Criteria used for interpretation of results: OECD GHS
Conclusions:
the LD50 of the test item is highter than 300 mg/kg body weight and lower than 2000 mg/kg body weight by oral route in the rat.
In accordance with the OCDE guideline N° 423, the LD50 cutt-off of the test item may be considered as 500 mg/kg body weight by oral route in the rat.
According to the criteria for classificatin, packing and labelling of dangerous substances and preparations in accodance with the EEC directives 67/548, 2001/59 and 99/45, the test item must be classified R22 " Harmful is swallowed". The item must be characterised by the symbol "Xn" and the warning label "Harmful".

In accordance with the GHS (regulation EC No 1272/2008, the test iem must be classified in categori 4. The signal word "Warning" and hazard statement H302 "Harmful if swallowed" are required.